Small molecule inhibitors for CLL: which to use, sequencing, switching and combinations
Dual FLT3/SYK oral inhibitor for AML: TAK-659
Prof. Rule’s data highlights from ICML 2017
Immunotherapy for AML and ALL: checkpoint inhibitors & CAR T-cells for B-cell ALL
John DiPersio et al.
Nivolumab in combination with azacitidine in patients with relapsed acute myeloid leukemia (AML)
Naval G. Daver